Vol 26, No 3 (2019)
Original articles — Clinical cardiology
Published online: 2017-07-14
Simple platelet markers: Mean platelet volume and congestive heart failure coexistent with periodontal disease. Pilot studies
Abstract
Background: Conducted pilot study concerning mean platelet volume (MPV) parameter among patients suffering from congestive heart failure and periodontal disease.
Methods: Examination of dynamic changes of platelet and periodontal markers in group of 50 patients before and an average of 6 months subsequent to professional periodontal treatment.
Results: Both platelet and periodontal parameters decreased after periodontal treatment, what is more, the decrease of MPV value due to periodontal disease/mm improvement was shown to be statistically significant (p = 0.05).
Conclusions: Improvement of periodontal status may influence decrease of MPV value and increase of congestive heart failure treatment efficacy and effect patient comfort. It is a new, not frequently used pattern of chronic disease treatment optimalization.
Keywords: mean platelet volumeplateletscongestive heart failureperiodontal diseaseinflammatory response
References
- Karataş MB, Çanga Y, İpek G, et al. Association of admission serum laboratory parameters with new-onset atrial fibrillation after a primary percutaneous coronary intervention. Coron Artery Dis. 2016; 27(2): 128–134.
- Bolat I, Akgul O, Cakmak HA, et al. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol. 2016; 74(4): 346–355.
- Sansanayudh N, Numthavaj P, Muntham D, et al. Prognostic effect of mean platelet volume in patients with coronary artery disease. A systematic review and meta-analysis. Thromb Haemost. 2015; 114(6): 1299–1309.
- Yılmaz F, Köklü E, Kizilirmak Yilmaz F, et al. Evaluation of mean platelet volume and platelet distribution width in patients with asymptomatic intermediate carotid artery plaque. Kardiol Pol. 2017; 75(1): 35–41.
- İleri M, Kanat S, Gürsoy HT, et al. Increased mean platelet volume in rheumatic mitral stenosis: assessment of clinical and echocardiographic determinants. Kardiol Pol. 2015; 73(1): 46–53.
- Łysek R, Szafraniec K, Polak M, et al. Relationship between past myocardial infarction, periodontal disease and Porphyromonas gingivalis serum antibodies: A case-control study. Cardiol J. 2018; 25(3): 386–392.
- Wożakowska-Kapłon B, Włosowicz M, Gorczyca-Michta I, et al. Oral health status and the occurrence and clinical course of myocardial infarction in hospital phase: a case-control study. Cardiol J. 2013; 20(4): 370–377.
- Androsz-Kowalska O, Jankowski K, Rymarczyk Z, et al. Correlation between clinical parameters of periodontal disease and mean platelet volume in patients with coronary artery disease: a pilot study. Kardiol Pol. 2013; 71(6): 600–605.
- Kandis H, Ozhan H, Ordu S, et al. The prognostic value of mean platelet volume in decompensated heart failure. Emerg Med J. 2011; 28(7): 575–578.
- Budak YU, Huysal K, Demirci H. Correlation between mean platelet volume and B-type natriuretic peptide concentration in emergency patients with heart failure. Biochem Med (Zagreb). 2015; 25(1): 97–102.
- Czerniuk M, Filipiak KJ, Górska R, et al. [Periodontal state and cardiovascular diseases]. Pol Arch Med Wewn. 1999; 101(5): 433–436.
- Czerniuk MR, Górska R, Filipiak KJ, et al. Inflammatory response to acute coronary syndrome in patients with coexistent periodontal disease. J Periodontol. 2004; 75(7): 1020–1026.
- Czerniuk MR, Górska R, Filipiak KJ, et al. C-reactive protein in patients with coexistent periodontal disease and acute coronary syndromes. J Clin Periodontol. 2006; 33(6): 415–420.
- Zaremba M, Górska R, Suwalski P, et al. Periodontitis as a risk factor of coronary heart diseases? Adv Med Sci. 2006; 51 Suppl 1: 34–39.
- Czerniuk MR, Gorska R, Filipiak KJ, et al. The influence of periodontal diseases on intensivity and dynamice of inflammation response in patients with acute coronary syndromes. Dent Med Probl. 2002; 39(1): 31–37.
- Czerniuk MR, Eickholz P, Grötz KA. Oral cavity infections: why should cardiologists care about them? Kardiol Pol. 2015; 73(10): 901–908.
- Czerniuk M, Bartoszewicz Z, Filipiak K, et al. Osoczowe stężenia NT-proBNP u pacjentów z niewydolnością serca i współistniejącą chorobą przyzębia: badania pilotażowe. Kardiol Pol. 2017; 75(2): 135–142.
- Saffi MA, Furtado MV, Polanczyk CA, et al. Relationship between vascular endothelium and periodontal disease in atherosclerotic lesions: Review article. World J Cardiol. 2015; 7(1): 26–30.
- Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107(3): 499–511.
- D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res. 2004; 83(2): 156–160.
- Higashi Y, Noma K, Yoshizumi M, et al. Endothelial function and oxidative stress in cardiovascular diseases. Circ J. 2009; 73(3): 411–418.
- de Araújo Júnior RF, Souza TO, de Medeiros CA, et al. Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitis. PLoS One. 2013; 8(7): e66391.
- Lange DE, Plagman HC, Eenboom A, et al. Klinische Bewertungsverfaren zur Obiekitiverung der Mundhygiene. Dtsch Zahnarztl Z. 1977; 32: 44–47.
- Hall WB. Critical Decisions in Periodontology. Fourth Edition, BC Decker Inc, Hamilton, London 2003: 30–31.
- Hall WB. Clinical Practice. In: Steele PF (ed). Dimensions of Dental Hygiene. Third Edition. Lea&Febiger, Philiadelphia 1982: 153.
- Dibart S, Dietrich T. Practical periodontal diagnostic and treatment planning. Chapter 2. Wiley-Blackwell, Iowa 2010.
- Kaisare S, Rao J, Dubashi N. Periodontal disease as a risk factor for acute myocardial infarction. A case-control study in Goans highlighting a review of the literature. Br Dent J. 2007; 203(3): 144–145.
- Ximénez-Fyvie LA, Haffajee AD, Socransky SS. Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. J Clin Periodontol. 2000; 27(9): 648–657.
- Dorn JM, Genco RJ, Grossi SG, et al. Periodontal disease and recurrent cardiovascular events in survivors of myocardial infarction (MI): the Western New York Acute MI Study. J Periodontol. 2010; 81(4): 502–511.
- Blair FM, Chapple ILC. Prescribing for periodontal disease. Prim Dent J. 2014; 3(4): 38–43.
- Chukkapalli SS, Velsko IM, Rivera-Kweh MF, et al. Polymicrobial oral infection with four periodontal bacteria orchestrates a distinct inflammatory response and atherosclerosis in apoe null mice. PLoS One. 2015; 10(11): e0143291.
- Beck JD, Eke P, Heiss G, et al. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation. 2005; 112(1): 19–24.
- Tonetti MS, Eickholz P, Loos BG, et al. Principles in prevention of periodontal diseases: Consensus report of group 1 of the 11(th) European Workshop on Periodontology on effective prevention of periodontal and peri-implant diseases. J Clin Periodontol. 2015; 42(Suppl 16): 5–11.
- Seymour RA. Is gum disease killing your patient? Br Dent J. 2009; 206(10): 551–552.
- Meyer-Bäumer A, Eick S, Mertens C, et al. Periodontal pathogens and associated factors in aggressive periodontitis: results 5-17 years after active periodontal therapy. J Clin Periodontol. 2014; 41(7): 662–672.
